XKRX
016800
Market cap162mUSD
Oct 08, Last price
24,400.00KRW
1D
1.46%
1Q
-8.10%
Jan 2017
-26.06%
Name
Fursys Inc
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Established in 1983 and headquartered in Seoul, South Korea, Fursys Inc. specializes in the creation, production, and distribution of a wide range of furniture. The company primarily furnishes office and residential spaces, offering items such as desks, modular partitioning systems, executive and lobby seating, complete conference and lecture setups, sofas, coffee tables, and various related accessories. Their portfolio also includes specialized furniture for libraries and student dormitories. Furthermore, Fursys Inc. caters to the healthcare sector, providing dedicated furnishings for areas like medical equipment zones, patient wards, clinical facilities, nursing stations, laboratory environments (including those for primary and secondary science education), staff workspaces, and patient waiting or resting areas. These products are marketed under the distinct brand names FURSYS, iloom, and SIDIZ.
Key people
Gwang Ho Park
Co-Chief Executive Officer, Director · since 2022
Sang Geun Park
Vice President, Director · since 2012
Min Yeong Choi
Internal Auditor · since 2010
Myeong Su Lee
Internal Auditor · since 2010
Jeong Seo
Assistant Managing Director · since 2013
Sang Don Bae
Co-Chief Executive Officer, Director · since 2022
Seok Goh
Non-Executive Independent Director · since 2013
Non-Executive Independent Director · since 2013
Jung Bae Son
Non-Executive Independent Director · since 2012
Valuation
Title KRW in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||